P67Phox Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@pphox] title: p67phox Protein [@microglial] :: infobox .infobox-protein ::
P67Phox Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@pphox] title: p67phox Protein [@microglial] :: infobox .infobox-protein ::
Overview
p67phox (Neutrophil Cytosolic Factor 2) is a 67 kDa cytosolic protein that is a essential component of the NADPH oxidase complex in phagocytic cells. It plays a critical role in generating [reactive oxygen species](/entities/reactive-oxygen-species) (ROS) during the oxidative burst, a process that is also implicated in neurodegenerative diseases through microglial activation.
Structure
p67phox contains several functional domains:
N-terminal PX domain: Targets the protein to membrane phosphoinositides
p67phox is a critical organizer of the NADPH oxidase complex assembly:
In resting cells, p67phox exists in the cytosol as a complex with p47phox and p40phox
Upon cell activation, the complex translocates to the membrane
p67phox brings Rac-GTP to the membrane complex
The assembled complex catalyzes electron transfer from NADPH to oxygen, generating superoxide
Signaling Roles
Beyond ROS production, p67phox participates in:
Cell signaling pathways
Cytoskeletal reorganization
Transcriptional regulation
Role in Disease
Alzheimer's Disease
In AD brain, p67phox expression is elevated in activated [microglia](/cell-types/microglia-neuroinflammation) surrounding amyloid plaques. The NADPH oxidase-derived ROS contributes to:
Oxidative damage to [neurons](/entities/neurons)
Acceleration of [amyloid-beta](/proteins/amyloid-beta) aggregation
Chronic neuroinflammation
Parkinson's Disease
Microglial NADPH oxidase, including p67phox, is a key mediator of dopaminergic neuron loss:
Activated microglia produce ROS that damages neurons
NADPH oxidase inhibition is neuroprotective in PD models
p67phox expression correlates with disease progression
Therapeutic Targeting
NADPH oxidase inhibitors are being investigated as potential neuroprotective agents:
Apocynin and related compounds
Targeted delivery to microglia
Combination with anti-inflammatory agents
Key Publications
[NADPH oxidase in neurodegenerative diseases (2010)](https://doi.org/10.1016/j.tins.2010.03.004)
[p67phox structure and function (2004)](https://doi.org/10.1016/j.tibs.2004.09.005)
[Microglial NADPH oxidase in PD therapy (2015)](https://doi.org/10.1016/j.neuropharm.2014.12.010)
The study of P67Phox Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
See Also
[NCF2 Gene](/genes/ncf2)
[CYBB Gene](/genes/cybb)
[NCF1 Gene](/genes/ncf1)
[Oxidative Stress](/mechanisms/oxidative-stress)
[Microglia](/cell-types/microglia)
References
Unknown, NADPH oxidase in neurodegenerative diseases - PubMed (n.d.)
Unknown, p67phox structure and function - PubMed (n.d.)
Unknown, Microglial NADPH oxidase in PD therapy - PubMed (n.d.)